Roflumilast Foam 0.3%
ARQ-154-309
Phase 3 small_molecule completed
Quick answer
Roflumilast Foam 0.3% for Scalp Psoriasis is a Phase 3 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Scalp Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed